China Hospital Industry Report, 2015-2018
  • Nov.2015
  • Hard Copy
  • USD $2,700
  • Pages:156
  • Single User License
    (PDF Unprintable)       
  • USD $2,500
  • Code: ZLC026
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,900
  • Hard Copy + Single User License
  • USD $2,900
      

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decline whereas private hospitals increased rapidly.

During the period from 2011 to late May2015, the number of private hospitals in China advanced 4,713, with the share up from 38.4% to 49.7%. But in point of revenue, China's private hospitals just accounted for 10%.

In terms of medical service, between January and May 2015, China saw 1.2152 billion hospital visits, up 5.4% from a year earlier. Although the number of public hospitals occupied only 50.3% of total hospitals, yet the public hospital visits represented up to 89.1%, which was mainly due to the fact that private hospitals are small in scale and have relatively poor treatment level and lower public awareness.

At present, more investment has gone to specialized hospitals, which have captured long-term attention from social capital, hence a great market demand. As of the end of 2014, the number of specialized hospitals in China were expected to reach 5,449, making up 21.4% of the total. Among them, mental hospitals, maternity hospitals, orthopaedic hospitals, stomatological hospitals, and ophthalmic hospitals constitute the mainstay. Tumor hospitals generated the most revenue while beauty hospitals, ophthalmic hospitals, and stomatological hospitals produced relatively higher profit margin.

In recent years, the State has introduced a series of favorable policies designed to encourage private capital into the hospital industry, thus setting off a wave of social capital inrush to medical service. Currently, many private companies including Aier Eye Hospital Group, TC Medical, Mayinglong Pharm, Shanghai Fosun Pharmaceutical (Group), Jinling Pharmaceutical Company Limited, and Phoenix Healthcare Group have ventured into the field of medical service. Among them, Aier Eye Hospital Group and Shanghai Fosun Pharmaceutical (Group) achieved good results in business development. In H1 2015, the medical service revenue for the two companies totaled RMB1.175 billion and RMB674.4 million, respectively.

As China's largest ophthalmic medical chain institution, Aier Eye Hospital Group have established more than 100 professional ophthalmic hospitals throughout the country, with over 3 million outpatient visits annually. In the past two years, the company set up four industrial merger & acquisition funds used to invest in grand health industry, in the hope of increasing hospital outlets and achieving industrial expansion.
?
Fosun Pharma specializes in drug manufacturing and research and development meanwhile operating medical service business. In recent years, through self-building, mergers and acquisitions, joint venturing, and affiliation, the company has made continuous expansion in medical service and seen explosive growth in revenue from this field. In 2011-2014, the company’s medical service revenue registered a CAGR of 371.5%. In 2014, the company participated in the privatization of Chindex International, Inc. (“Chindex”), and upon the completion of the privatization transaction, Fosun Industrial held a 42.927% equity interest and at the same time owned “United Family Hospital”, a high-end brand for healthcare services under Chindex.

医院 英文_副本.png

The report highlights the followings:
20120114.gifOverview of China hospital industry, including number of hospitals, revenue, medical service, competition pattern, summary and forecast, etc.;
20120114.gifStatus quo of specialized hospitals in China, including overall operation, development of specialized hospitals of all sorts, etc.;
20120114.gifDevelopment prediction of China hospital industry, including the impact of medical insurance system and urbanization on hospital industry, etc.;
20120114.gifInvestment in China hospital industry, including related policies, comparison of public and private hospitals, investment opportunities of social capital, and development model of foreign-funded hospitals, etc.;
20120114.gifOperation, and medical service business of 16 enterprises venturing into hospital industry.

1. Overview of China Hospital Industry
1.1 Definition 
1.2 Classification 
1.3 Industry Chain

2. Development of China Hospital Industry
2.1 Overview
2.1.1 Number of Hospitals
2.1.2 Distribution
2.2 Revenue 
2.2.1 Total Revenue
2.2.2 General Hospitals
2.3 Medical Service 
2.4 Competition Pattern
2.5 Summary and Forecast

3. Development of Specialized Hospitals in China 
3.1 Overview 
3.1.1 Number of Hospitals
3.1.2 Revenue
3.2 Status Quo of Specialized Hospitals of All Kinds
3.2.1 Ophthalmic Hospital 
3.2.2 Stomatological Hospital
3.2.3 Orthopedics & Beauty Hospital
3.2.4 Maternity Hospital Obstetrics and Gynecology Hospital
3.2.5 Children’s Hospital
3.2.6 Tumor Hospital

4. Development Forecast of China Hospital Industry
4.1 Status Quo of China Medical Insurance
4.1.1 Medical Insurance System 
4.1.2 Medical Insurance Close to Saturation
4.1.3 Medical Insurance for Serious Illness of Urban and Rural Residents
4.2 Urbanization Bolsters Development of the Hospital Industry
4.2.1 Status Quo of Urbanization in China 
4.2.2 Urbanization Expects to Optimize Medical Insurance System 
4.2.3 Trans-regional Medical Insurance Settlement is to be advanced
4.2.4 Urbanization Incrementation Depends on the Contribution of Medical Insurance System 
4.2.5 Medical Insurance Fund Balance Rate Will See Further Decrease 
4.2.6 Medical Resource Supply of County-Level Hospitals Will Improve 
4.2.7 Urbanization Will Encourage Central Government to Invest in Urban Medical Resources

5. Investment in China Hospital Industry
5.1 Impetus Given by Policies
5.2 Comparison of Public and Private Hospitals
5.2.1 Public Hospitals Play a Leading Role
5.2.2 Private Hospitals Run with Efficiency
5.3 Investment Opportunities of Social Capital 
5.3.1 Specialized Medical Field
5.3.2 General Public Hospitals 
5.4 Development Orientation and Business Model of Foreign Hospitals
5.4.1 Status Quo of Foreign Hospitals in China 
5.4.2 Development Direction
5.4.3 Business Practice

6. Major Private Hospitals in China 
6.1 Aier Eye Hospital Group
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Gross Margin
6.1.5 R&D and Investment
6.1.6 Medical Service
6.1.7 Prediction and Outlook
6.2 TC Medical
6.2.1 Profile
6.2.2 Operation
6.2.3 Revenue Structure
6.2.4 Gross Margin
6.2.5 Medical Service
6.2.6 Prediction and Outlook
6.3 Mayinglong Pharm
6.3.1 Profile
6.3.2 Operation
6.3.3 Revenue Structure
6.3.4 Gross Margin
6.3.5 R&D and Investment
6.3.6 Medical Service
6.3.7 Prediction and Outlook
6.4 Shanghai Fosun Pharmaceutical (Group)
6.4.1 Profile
6.4.2 Operation
6.4.3 Revenue Structure
6.4.4 Gross Margin
6.4.5 R&D and Investment
6.4.6 Medical Service
6.4.7 Prediction and Outlook
6.5 Jinling Pharmaceutical Company Limited
6.5.1 Profile
6.5.2 Operation
6.5.3 Revenue Structure
6.5.4 Gross Margin
6.5.5 R&D and Investment
6.5.6 Medical Service
6.5.7 Prediction and Outlook
6.6 Shinva Medical
6.6.1 Profile
6.6.2 Operation
6.6.3 Revenue Structure
6.6.4 Gross Margin
6.6.5 R&D and Investment
6.6.6 Medical Service
6.6.7 Prediction and Outlook
6.7 Xi’an International Medical Investment Co., Ltd.
6.7.1 Profile
6.7.2 Operation
6.7.3 Revenue Structure
6.7.4 Medical Service
6.7.5 Prediction and Outlook
6.8 Inner Mongolia Furui Medical Science 
6.8.1 Profile
6.8.2 Operation
6.8.3 Revenue Structure
6.8.4 Medical Service
6.8.5 Prediction and Outlook
6.9 Wuhan Jianmin Pharmaceutical Groups Corp.
6.9.1 Profile
6.9.2 Operation
6.9.3 Revenue Structure
6.9.4 Medical Service
6.9.5 Prediction and Outlook
6.10 Concord Medical Services Holdings Limited
6.10.1 Profile
6.10.2 Operation
6.10.3 Medical Service
6.10.4 Prediction and Outlook
6.11 Phoenix Healthcare Group
6.11.1 Profile
6.11.2 Operation
6.11.3 Medical Service
6.11.4 Prediction and Outlook
6.12 Guizhou Yibai Pharmaceutical
6.12.1 Profile
6.12.2 Operation
6.12.3 Medical Service
6.12.4 Prediction and Outlook
6.13 Kangmei Pharmaceutical
6.13.1 Profile
6.13.2 Operation
6.13.3 Medical Service
6.13.4 Prediction and Outlook
6.14 JNMPT 
6.14.1 Profile
6.14.2 Operation
6.14.3 Medical Service
6.14.5 Prediction and Outlook
6.15 China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
6.15.1 Profile
6.15.2 Operation
6.15.3 Medical Service
6.16 Parkway Pantai
6.16.1 Profile
6.16.2 Development in China
China’s Hospital Industry Chain 
Number and Increment of Hospitals in China, 2009-2015
Number of Hospitals in China by Level, 2009-2015
Percentage of Hospitals in China by Level as of the end of May 2015
Number of Hospitals in China by Economic Type, 2009-2015   
Number of Hospitals in China by Economic Type, 2009-2015
Number of Hospitals in China by Type, 2009-2014
Number of Hospitals in China by Region as of the end of May 2015
Total Revenue and YoY Growth of Hospitals in China 2009-2014
Gross Margin of Hospitals in China, 2009-2014 
Revenue Structure of China Hospital Industry by Source, 2013
Revenue Structure of China Hospital Industry by Type, 2013
Average Revenue and YoY Growth of General Hospitals in China 2009-2014
Average Revenue of Each General Hospital in China by Business, 2009-2013
Number of Visits to China’s Hospitals, 2009-2015   
Bed Utilization in China’s Hospitals, 2009-2015 
Number of Visits to China’s Hospitals by Economic Type, 2012-2015
Structure of Chinese Hospital Visits by Economic Type, Jan.-May, 2015
Number of Visits to China’s Hospitals by Hospital Level, 2012-2015
Structure of Chinese Hospital Visits by Hospital Level, Jan.-May, 2015
Bed Utilization in China’s Hospitals by Hospital Level, 2009-2015
Proportion of Public Medical Institutions and Private Hospitals by Type, 2013   
Medical Service Revenue of Major Private Hospitals in China, 2012-2015
Revenue of Major Chinese Private Hospitals, 2014-2018E
Number and Increment of Hospitals in China, 2014-2018E
Number of Specialized Hospitals and % of Total Hospitals in China, 2014-2018E
Revenue and YoY Growth of Hospitals in China, 2014-2018E
Revenue of Hospitals in China by Economic Type, 2014-2018E
Revenue from Specialized Hospitals and % of Total Revenue in China, 2014-2018E
Number of Specialized Hospitals and % of Total Hospitals in China, 2009-2014
Proportion of Specialized Hospitals in China by Economic Type, 2009-2014
Number of Specialized Hospitals in China by Type, 2010-2013
Proportion of Specialized Hospitals in China by Revenue, 2009-2014
Revenue from Specialized Hospitals in China by Type, 2010-2013
Operating Margin of Specialized Hospitals in China by Type, 2010-2013
Number of Ophthalmic Hospitals in China by Economic Type, 2009-2014   
Total Revenue and Profits of Ophthalmic Hospitals in China, 2006-2013
Utilization of Hospital Beds and Service Efficiency of Doctors of Ophthalmic Hospitals in China, 2006-2013
Number of Stomatological Hospitals in China by Economic Type, 2009-2014   
Total Revenue and Profits of Stomatological Hospitals in China, 2006-2013   
Utilization of Hospital Beds and Workload of Doctors of Stomatological Hospitals in China, 2006-2013 
Number and Distribution of Major Private Stomatological Medical Institutions and Their Chains in China, 2015
Plastic Surgery & Cosmetic Hospitals in China by Economic Type, 2009-2014 
Total Revenue and Profits of Plastic Surgery & Cosmetic Hospitals in China, 2006-2013  
Number of Maternity Hospitals in China by Economic Type, 2009-2014   
Total Revenue and Profits of Maternity Hospitals in China, 2006-2013  
Utilization of Hospital Beds and Workload of Doctors of Maternity Hospitals in China, 2006-2013  
Number of Children’s Hospitals in China by Economic Type, 2009-2014   
Total Revenue and Profits of Children’s Hospitals in China, 2006-2013  
Utilization of Hospital Beds and Workload of Doctors of Children’s Hospitals, 2006-2013      
Number of Tumor Hospitals in China by Economic Type, 2009-2014   
Total Revenue and Profits of Tumor Hospitals in China, 2006-2013  
Utilization of Hospital Beds and Workload of Doctors of Tumor Hospitals in China, 2006-2013     
Structure of Medical Insurance System in China
Population Covered under China’s Urban Medical Insurance, 2008-2014
Urbanization Rate of China, 2000-2014 
China’s Healthcare Expenditure Structure, 2005-2014
Medical Insurances of China’s Urban Workers and Balance Rate of New Rural Cooperative Medical System, 2005-2014
Favorable Polices on the Construction of County-Level Hospitals, 2009-2014 
Landmark Events on Social Capitals Flowing to Medical Service Field in China, 1985-2014 
Policies on Social Capitals Flowing to Medical Service Field in China, 2009-2015
Differences in Policies on China’s Private and Public Hospitals 
Entrustment Chain of Public Hospitals in China 
Revenue and Market Share of Public Hospitals in China, 2008-2014
Revenue and Market Share of Private Hospitals in China, 2008-2014
Comparison of China’s Major Medical Service-related Special projects
Trends towards Marketization of Medical Service System in China
Reform Mode of Established Property Rights System of Public Hospitals
Pilot Cases of China’s Social Capitals Contributing to Public Hospital Restructuring, 1999-2015 
Partners and Major Medical Treatment Services of Sino-Foreign Joint Ventures in China
Partners and Major Services of Sino-Foreign Joint Ventures in China
Revenue and Net Income of Aier Eye Hospital Group, 2011-2015
Net Income of Aier Eye Hospital Group’s Major Subsidiaries , 2015H1
Revenue of Aier Eye Hospital Group by Business, 2009-2015
Revenue of Aier Eye Hospital Group by Region, 2009-2014  
Revenue Structure of Aier Eye Hospital Group by Region, 2009-2014      
Gross Margin of Aier Eye Hospital Group by Business,2009-2014      
R&D Costs and % of Total Revenue of Aier Eye Hospital Group, 2012-2014      
Medical Service Revenue and % of Total of Aier Eye Hospital Group, 2009-2015   
Revenue and Net Income of Aier Eye Hospital Group, 2014-2018E   
Revenue and Net Income of TC Medical, 2011-2015      
Revenue of TC Medical by Business, 2012-2015   
Revenue of TC Medical by Region, 2012-2015   
Revenue Structure of TC Medical by Region, 2012-2015   
Gross Margin of TC Medical, 2012-2015   
Gross Margin of TC Medical by Business, 2012-2015   
Client Orientation of TC Medical
Revenue and Net Income of TC Medical’s Major Subsidiaries, 2013-2014 
Revenue and Net Income of TC Medical, 2014-2018E   
Revenue and Net Income of Mayinglong Pharm, 2011-2015   
Revenue of Mayinglong Pharm by Product, 2012-2015     
Revenue Structure of Mayinglong Pharm by Product, 2012-2015  
Revenue of Mayinglong Pharm by Region, 2012-2015      
Revenue Structure of Mayinglong Pharm by Region, 2012-2015   
Gross Margin of Mayinglong Pharm by Product, 2012-2015   
R&D Costs and % of Total Revenue of Mayinglong Pharm, 2012-2015   
Key R&D Projects of Mayinglong Pharm, 2015  
Establishment Mode and Equity Structure of Anorectum Hospitals under Mayinglong Pharm
Revenue and Net Income of Mayinglong Pharm, 2014-2018E 
Revenue and Net Income of Shanghai Fosun Pharmaceutical (Group), 2011-2015    
Revenue of Shanghai Fosun Pharmaceutical (Group) by Business, 2011-2015     
Revenue Structure of Shanghai Fosun Pharmaceutical (Group) by Business, 2011-2015   
Revenue of Shanghai Fosun Pharmaceutical (Group) by Region, 2011-2015      
Revenue Structure of Shanghai Fosun Pharmaceutical (Group) by Region, 2011-2015      
Gross Margin of Shanghai Fosun Pharmaceutical (Group) by Business, 2011-2015    
R&D Costs and % of Total Revenue of Shanghai Fosun Pharmaceutical (Group), 2012-2015   
Number and Subscription Amount of Shares through Private Placement of Shanghai Fosun Pharmaceutical (Group), 2015  
Medical Service Revenue and % of Total of Shanghai Fosun Pharmaceutical (Group), 2011-2015   
Revenue and Net Income of Shanghai Fosun Pharmaceutical (Group), 2014-2018E 
Revenue and Net Income of Jinling Pharmaceutical, 2011-2015   
Revenue of Jinling Pharmaceutical by Product, 2011-2015      
Revenue Structure of Jinling Pharmaceutical by Product, 2011-2015     
Revenue of Jinling Pharmaceutical by Region, 2012-2015     
Revenue Structure of Jinling Pharmaceutical by Region, 2012-2015      
Gross Margin of Jinling Pharmaceutical by Product, 2011-2015    
R&D Costs and % of Total Revenue of Jinling Pharmaceutical, 2012-2015     
Medical Service Revenue and % of Total of Jinling Pharmaceutical, 2011-2015
Revenue and Net Income of Jinling Pharmaceutical, 2014-2018E
Revenue and Net Income of Shinva Medical, 2011-2015  
Revenue of Shinva Medical by Product, 2011-2015     
Revenue Structure of Shinva Medical by Product, 2011-2015      
Revenue of Shinva Medical by Region, 2011-2015      
Revenue Structure of Shinva Medical by Region, 2011-2015     
Gross Margin of Shinva Medical by Product, 2011-2015   
R&D Costs and % of Total Revenue of Shinva Medical, 2012-2014     
Revenue and Net Income of Shinva Medical, 2014-2018E   
Revenue and Net Income of Xi'an International Medical Investment, 2011-2015   
Revenue of Xi'an International Medical Investment by Segment, 2012-2015    
Revenue Structure of Xi'an International Medical Investment by Segment, 2012-2015
Revenue of Xi'an International Medical Investment by Region, 2011-2015
Revenue Structure of Xi'an International Medical Investment by Region, 2011-2015
Medical Service Revenue and % of Total of Xi'an International Medical Investment, 2012-2015   
Revenue and Net Income of Xi'an International Medical Investment, 2011-2015    
Issue Objects for the Private Placement, Their Placement Shares, and Subscription Amount of Xi'an International Medical Investment, 2015
Revenue and Net Income of Xi'an International Medical Investment, 2014-2018E   
Revenue and Net Income of Inner Mongolia Furui Medical Science, 2011-2015     
Revenue of Inner Mongolia Furui Medical Science by Product, 2011-2015        
Revenue Structure of Inner Mongolia Furui Medical Science by Product, 2011-2015        
Revenue and Net Income of Inner Mongolia Furui Medical Science, 2014-2018E     
Revenue and Net Income of Wuhan Jianmin Pharmaceutical Groups Corp., 2011-2015    
Revenue of Wuhan Jianmin Pharmaceutical Groups Corp. by Segment, 2012-2015
Revenue Structure of Wuhan Jianmin Pharmaceutical Groups Corp. by Segment, 2012-2015   .   
Revenue of Wuhan Jianmin Pharmaceutical Groups Corp. by Region, 2011-2015       
Revenue Structure of Wuhan Jianmin Pharmaceutical Groups Corp. by Region, 2011-2015     
Revenue and Net Income of Wuhan Jianmin Pharmaceutical Groups Corp., 2014-2018E   
Revenue and Net Income of Concord Medical Services Holdings Limited, 2011-2015   
Coverage of Service Network of Concord Medical Services Holdings Limited
Revenue and Net Income of Concord Medical Services Holdings Limited, 2014-2018E   
Revenue and Net Income of Phoenix Healthcare Group, 2011-2015  
General Hospital Service Revenue and YoY Growth of Phoenix Healthcare Group, 2011-2015
Hospital Management Service Revenue Structure of Phoenix Healthcare Group by Hospital, 2014
Revenue and Net Income of Phoenix Healthcare Group, 2014-2018E 
Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2011-2015   
Medical Service Revenue and % of Total of Guizhou Yibai Pharmaceutical, 2011-2015
Revenue and Net Income of Guizhou Yibai Pharmaceutical, 2014-2018E  
Revenue and Net Income of Kangmei Pharmaceutical, 2011-2015  
Revenue and Net Income of Kangmei Pharmaceutical, 2014-2018E 
Revenue and Net Income of JNMPT, 2011-2015    
Revenue and Net Income of JNMPT, 2014-2018E
Revenue and Net Income of China Resources Sanjiu Medical & Pharmaceutical Co., 2011-2015
Medical Service Revenue and YoY Growth of China Resources Sanjiu Medical & Pharmaceutical Co., 2009-2013
Parkway Pantai Medical’s Centers and Services in China

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号